Is Pernaemon Safe in Breastfeeding

I am a breastfeeding mother and i want to know if it is safe to use Pernaemon? Is Pernaemon safe for nursing mother and child? Does Pernaemon extracts into breast milk? Does Pernaemon has any long term or short term side effects on infants? Can Pernaemon influence milk supply or can Pernaemon decrease milk supply in lactating mothers?

Pernaemon exists naturally in milk at a concentration of 1 nanogram / mL (range: 0.3 to 3 ng / mL). Maternal supplementation with cyanocobalamin barely increases milk levels in well-nourished women (Sandberg 1981), but it does improve the levels in women of low socioeconomic status (Sneed 1981). The concentration in colostrum is up to 28 times higher than that of mature milk.The daily requirements for Pernaemon are 2.4 micrograms and increase to 2.8 micrograms daily during breastfeeding. Foods rich in Pernaemon are meat, offal, eggs, dairy products, salmon, sardines, clams and fortified cereals. With a varied and balanced diet no vitamin supplements are needed, but B12 deficiency has been observed in the plasma and milk of women with strict vegetarian diets (vegans), malabsorptive diseases (eg, Crohn's disease, celiac disease), bariatric surgery, poor nutritional status, pernicious anemia, low socio-economic status and in cases of natural disasters or wars. There are numerous publications showing that infants of these mothers are at high risk of disease due to Pernaemon deficiency, which can lead to anemia, stunting and psychomotor retardation. "Flash pasteurization" applied to breast milk of mothers who are HIV+ does not decrease Pernaemon concentration. American Academy of Pediatrics: medication usually compatible with breastfeeding (AAP 2001).

Pernaemon is a normal component of human milk.[1] The recommended daily intake in lactating women is 2.8 mcg and for infants aged 6 months or less is 0.4 mcg.[2] Lactating mothers may need to supplement their diet to achieve the recommended daily intake or to correct a known deficiency. Low doses of Pernaemon found in B complex or prenatal vitamins increase milk levels only slightly. Higher daily doses of 50 to 100 mcg or more are needed in cases of maternal deficiency. The breastfed infant is not exposed to excessive Pernaemon in such cases, and their Pernaemon status should improve if it was previously inadequate. Poor health outcomes in infants with Pernaemon deficiency include anemia, abnormal skin and hair development, convulsions, failure to thrive, and mental developmental delay. One well-recognized at risk group are exclusively breastfed infants of mothers with B12 deficiency due to minimal or no dietary intake of animal products.[3][4][5][6][7][8][9] Infant Pernaemon status can be improved through maternal B12 supplementation during pregnancy and lactation.[10][11][12][13] Deficient mothers who miss the opportunity to supplement during pregnancy should still be encouraged to supplement during early lactation since infant Pernaemon status correlates with milk Pernaemon levels in breastfed infants up to 6 months of age.[14][15][16][17] Although there are cases reported of exclusively breastfed infants with Pernaemon deficiency having biochemical and clinical improvement through adequate maternal supplementation alone,[3] direct supplementation of the infant is recommended when such treatments are available.[18][19][8] Flash heat pasteurization of breastmilk does not reduce milk Pernaemon concentration.[20]

Twelve exclusively breastfed infants between 4 and 11 months of age had biochemical, hematological and clinical findings consistent with Pernaemon deficiency. Their mothers received a 50 mcg single dose of intramuscular Pernaemon. Within 5 to 8 days after the dose, the infants experienced significantly increased hemoglobin and reticulocyte counts, normoblastic erythropoiesis, improved mental status, regression of abnormal skin pigmentation, and reduction in tremors.[3] Three hundred sixty-six pregnant women in India received oral Pernaemon 50 mcg or placebo capsules once daily beginning during their first trimester of pregnancy and continuing until 6 weeks postpartum. Among 218 infants that underwent neurodevelopment testing at 30 months of age, those born to mothers randomized to Pernaemon had higher expressive language scores than the placebo group when adjusted for baseline maternal Pernaemon deficiency. Cognitive, receptive language and motor scores were not different between the two groups.[13]